Panacea Biotec Ltd.

View in App
160.75 +4.15 ▲2.7%

01 December 2023, 04:06:40 PM
Volume: 486,916

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.panaceabiotec.com
Market Cap 984.30 Cr.
Enterprise Value(EV) 857.09 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.53 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 104.94 Trailing Twelve Months Ending 2023-09
Industry PE 38.75 Trailing Twelve Months Ending 2023-09
Book Value / Share 138.28 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.16 Calculated using Price: 160.70
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 6.13 Cr. 61,250,746 Shares
FaceValue 1
About Panacea Biotec Ltd.
The company has product portfolio that's caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal. Business Areas of the Company :- (1) Research and Development (R&D) – Under this the company primarily focuses on New Chemical Entities (NCE), New Biological Entities (NBE) and Novel Drug Delivery System (NDDS). (2) Vaccines- Under this the company has product portfolio of oral polio vaccines and Hepatitis-B vaccines. (3) Formulations- It has created flagship brands like Willgo for pain management, Glizid & Glizid-M for diabetes; Panimun Bioral and Mycept for kidney transplant.

Panacea Biotec Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Panacea Biotec Ltd. Performance

View details >>
1 Day
+2.65%
1 Week
+2.88%
1 Month
+3.01%
3 Month
+17.25%
6 Month
+35.31%
1 Year
+15.94%
2 Year
-27.75%
5 Year
+9.47%
10 Year
+58.77%

Panacea Biotec Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -253.03 -34.38 -22.94 11.39 -75.26 332.85 -3.92
Return on Capital Employed (%) 0.45 9.93 2.76 2.63 13.44 -0.38 5.36 217.12 1.94
Return on Assets (%) -4.87 -1.01 -2.97 -4.53 2.55 -13.36 -10.69 74.05 -2.24

Panacea Biotec Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 471 449 356 309 350 199 -229 877 844 847
Non Curr. Liab. 918 1,100 719 591 70 741 960 85 99 97
Curr. Liab. 706 475 689 696 938 622 447 774 330 332
Minority Int. 3 1 11 -3 -3 -3 -3 -3 -3 -4
Equity & Liab. 2,099 2,025 1,774 1,592 1,356 1,559 1,177 1,735 1,271 1,272
Non Curr. Assets 1,573 1,475 1,071 1,028 848 875 666 745 703 737
Curr. Assets 526 549 703 565 508 683 474 951 562 535
Misc. Exp. not W/O
Total Assets 2,099 2,025 1,774 1,592 1,356 1,559 1,177 1,735 1,271 1,272

Panacea Biotec Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 687 653 544 593 457 544 625 661 460 516
Other Income 28 20 47 8 5 30 10 11 52 38
Total Income 716 673 591 601 462 574 635 672 512 555
Total Expenditure -643 -541 -497 -508 -590 -519 -548 -674 -558 -545
PBIDT 72 132 94 93 -128 56 87 -2 -46 10
Interest -105 -127 -101 -101 -105 -174 -185 -181 -4 -4
Depreciation -67 -73 -68 -59 -55 -44 -46 -44 -39 -38
Taxation -3 -2 11 -10 -9 -17 -2 -371 -47 -37
Exceptional Items 50 8 334 -15 1,676 103 78
PAT -102 -21 -56 -76 38 -195 -146 1,078 -34 9
Minority Interest 2 2 2 2 0 0 0 0 1
Share Associate -6 0 0 0 0 0
Other Related Items
Consolidated Net Profit -107 -18 -54 -74 38 -194 -148 1,078 -33 9
Adjusted EPS -17 -3 -9 -12 6 -32 -24 176 -5 2

Panacea Biotec Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 54 37 91 131 118 105 -30 107 -108 -422
Cash Fr. Inv. -38 -37 16 -26 55 -5 -35 -48 1,283 430
Cash Fr. Finan. -30 -1 -117 -107 -164 -101 91 -47 -1,176 -18
Net Change -14 -1 -10 -2 9 -2 26 12 -2 -10
Cash & Cash Eqvt 21 20 10 7 16 14 40 52 50 40

Panacea Biotec Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 73.59 73.59 73.59 73.59 73.59 73.59 73.59 73.59 73.59
Public 26.41 26.41 26.41 26.41 26.41 26.41 26.41 26.41 26.41
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 94.27 94.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Panacea Biotec Ltd. Announcements

View details >>
Fri, 17 Nov 2023
Code of Conduct under SEBI(PIT) Reg., 2015
Panacea Biotec Limited has informed the Exchange about Code of Conduct under SEBI(PIT) Reg., 2015
Thu, 16 Nov 2023
Code of Conduct under SEBI(PIT) Reg., 2015
Panacea Biotec Limited has informed the Exchange about Code of Conduct under SEBI(PIT) Reg., 2015
Sun, 12 Nov 2023
Copy of Newspaper Publication
Panacea Biotec Limited has informed the Exchange about publication of Extract of Statement of Unaudited Financial Results for the quarter and half year ended 30.09.2023, in the newspapers on 11.11.2023

Panacea Biotec Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low

Panacea Biotec Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Panacea Biotec Ltd. FAQ's

What is Panacea Biotec share price?
Can I buy Panacea Biotec shares now?
What is the Market Cap of Panacea Biotec?
What are the key metrics to analyse Panacea Biotec?
What is the 52 Week High and Low of Panacea Biotec?
What is the trend of Panacea Biotec share price?